I would be the first patient for Loma Linda. The research I referred was not research done by Dr. Katerlos and Loma Linda UMC, but were studies that Dr. Katerelos used to make his determination that 7 days x 3 g is the best protocol.

These are the articles describing the studies that he cited in his letter to Medicare about RT being a standard of care for Dupuytren's. Both articles are by recognized names. Here is the bibliographical information that he put in the letter for me to send to Medicare:

1. Keilholz, L., Radiotherapy for Disease Progression in Early-Stage Dupuytren's Contracture: Initial and Long-term Results.
Int. J Radiation Oncology Biol. Phys. Vol. 36. No. 4pp. 891-897. 1996.

2. Seegenschmiedt, M etal, Optimization of radiotherapy for Dupuytren's disease. Stahlenther Onkol, 2001.

He put weight on the fact that the study using 7 days x 3 g used random results (I think it was results that were random, but I'm not sure.) Whatever (results, subjects, or ?), he says random studies are the "gold standard" for research. I don't know much about research, but I have heard about the value of random studies. Maybe somebody can educate me more about the validity of research.

I found the articles somewhere, but I don't have them now. They may even be on this website. If not, maybe somebody could access them and see if they could be published on this site.

The 7 days X 3g is on time only for a total of 21g.